bit.bio

Biotechnology · Cambridge, United Kingdom · Founded 2016 · Privately Held (backing)

Developer of a synthetic biology platform designed to provide human cells for research, drug discovery and cell therapy. bit.bio is based in Cambridge, United Kingdom and was founded in 2016. It was valued at $546 million at its later-stage round in Dec 2021, the last priced event on record. It has raised $234 million across 1 recorded round; the latest was a $138 million later-stage round in Dec 2021.

PMV mark · valuation
$546.3M
Oct 2026
Priced at
its later-stage round
Dec 2021
Total raised
$234.2M
Last round
Later Stage VC
Dec 2021
What is bit.bio worth?
$546.3MPrivateMarketView mark · Oct 2026

Valued at $546.3M at its later-stage round, Dec 2021. Nothing has traded since.

Free account
More of bit.bio with a free account
  • ·The complete investor list: 35 names
  • ·Watch bit.bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

bit.bio funding history

1 rounds
DateRoundRaisedPost-money
Dec 2021Later Stage VC$138.3M▮
Unlock post-money valuations

Membership and data by Private Market View

bit.bio valuation

bit.bio was valued at $546 million at its later-stage round in Dec 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has bit.bio raised?

bit.bio has raised $234 million in total; 1 of its rounds is on record. The largest on record was a $138 million later-stage round in Dec 2021.

Comparable companies

Comparable biotechnology names by valuation on PrivateMarketView: DNA Script ($660 million), Odyssey Therapeutics ($638 million) and Profluent ($525 million).

How bit.bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For bit.bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about bit.bio

What is bit.bio worth?
bit.bio is valued at $546.3M as of Oct 2026. Valued at $546.3M at its later-stage round, Dec 2021. Nothing has traded since.
How much has bit.bio raised?
bit.bio has raised $234.2M in total funding across 1 recorded rounds.
When did bit.bio last raise?
bit.bio last raised in Dec 2021 (Later Stage VC), raising $138.3M.